ES2000864A6 - Procedimiento para la obtencion de una formulacion promotora del crecimiento de los animales - Google Patents

Procedimiento para la obtencion de una formulacion promotora del crecimiento de los animales

Info

Publication number
ES2000864A6
ES2000864A6 ES8601040A ES8601040A ES2000864A6 ES 2000864 A6 ES2000864 A6 ES 2000864A6 ES 8601040 A ES8601040 A ES 8601040A ES 8601040 A ES8601040 A ES 8601040A ES 2000864 A6 ES2000864 A6 ES 2000864A6
Authority
ES
Spain
Prior art keywords
growth promoting
prolonged release
promoting hormones
growth
hormones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601040A
Other languages
English (en)
Inventor
Jerome L Martin
John F Kraemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Minerals and Chemical Corp
Original Assignee
International Minerals and Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Minerals and Chemical Corp filed Critical International Minerals and Chemical Corp
Publication of ES2000864A6 publication Critical patent/ES2000864A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UNA FORMULACION PROMOTORA DEL CRECIMIENTO DE LOS ANIMALES, CARACTERIZADO PORQUE COMPRENDE FORMAR UN COMPLEJO METALICO DE UNA HORMONA PROMOTORA DEL CRECIMIENTO POR COMBINACION DE UN METAL DE TRANSICION Y DE UNA HORMONA PROMOTORA DEL CRECIMIENTO EN UNA SOLUCION ACUOSA, ESTANDO ELEGIDA DICHA HORMONA, PREFERENTEMENTE DEL GRUPO FORMADO POR LAS HORMONAS PROMOTORAS DEL CRECIMIENTO DE GANADO EQUINO, DE LOS SERES HUMANOS, DE GANADO AVIAR, DE GANADO PORCINO, DE GANADO OVINO Y DE GANADO PORCINO, SIENDO ESPECIALMENTE PREFERENTE LA HORMONA DEL GANADO PORCINO, Y ELIGIENDOSE DICHO METAL DE TRANSICION DEL GRUPO QUE COMPRENDE ZINC, SOBRE MANGANESO, COBALTO Y HIERRO, SIENDO ESPECIALMENTE PREFERENTE EL ZINC.
ES8601040A 1985-08-12 1986-08-12 Procedimiento para la obtencion de una formulacion promotora del crecimiento de los animales Expired ES2000864A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76440085A 1985-08-12 1985-08-12

Publications (1)

Publication Number Publication Date
ES2000864A6 true ES2000864A6 (es) 1988-03-16

Family

ID=25070628

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601040A Expired ES2000864A6 (es) 1985-08-12 1986-08-12 Procedimiento para la obtencion de una formulacion promotora del crecimiento de los animales

Country Status (12)

Country Link
EP (1) EP0216485A1 (es)
JP (1) JPS6248635A (es)
KR (1) KR870001825A (es)
CN (1) CN86105023A (es)
AU (1) AU596112B2 (es)
BR (1) BR8603848A (es)
DK (1) DK384286A (es)
ES (1) ES2000864A6 (es)
IL (1) IL79681A (es)
NZ (1) NZ217175A (es)
PT (1) PT83187B (es)
ZA (1) ZA866052B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343696B1 (en) * 1984-10-04 1996-01-03 Monsanto Company Zinc-associated somatotropins
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
PL270368A1 (en) * 1987-01-30 1988-10-13 Int Minerals & Chem Corp Method for recovery of somatotropins from diluted water solutions
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US5122512A (en) * 1988-09-12 1992-06-16 Pitman-Moore, Inc. Swine growth promoting composition
AU653325B2 (en) * 1990-02-12 1994-09-29 Lucky Limited A composition durably releasing bioactive polypeptides
DK168790D0 (es) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
US6894023B1 (en) 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
WO1992017200A2 (en) * 1991-03-28 1992-10-15 Genentech, Inc. Stable growth hormone metal ion formulations
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
EP0779806B2 (en) * 1994-09-09 2008-04-16 Takeda Pharmaceutical Company Limited Sustained release preparation containing metal salt of a peptide
ATE268591T1 (de) 1995-06-27 2004-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
US6191107B1 (en) * 1997-09-26 2001-02-20 Takeda Chemical Industries, Ltd. Complex of human growth hormone and zinc
US6451347B1 (en) * 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
KR20090007504A (ko) 2000-02-24 2009-01-16 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
DK1274459T3 (da) 2000-04-19 2006-02-06 Genentech Inc Præparater med vedholdende frigivelse indeholdende væksthormon
WO2002000261A2 (en) 2000-06-26 2002-01-03 Monsanto Technology Llc Surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP2004515467A (ja) 2000-08-07 2004-05-27 ネクター セラピューティックス 吸入可能な、噴霧乾燥した、最少の凝集物を有する４−ヘリックスバンドルタンパク質粉末
DK1372729T3 (da) 2001-02-23 2009-06-22 Genentech Inc Nedbrydelige polymere til injektion
WO2003000282A1 (en) * 2001-06-21 2003-01-03 Genentech, Inc. Sustained release formulation
SG176314A1 (en) 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
CA2512001A1 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
NZ600363A (en) 2009-12-21 2014-07-25 Ambrx Inc Modified porcine somatotropin polypeptides and their uses
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB885798A (en) * 1958-12-06 1961-12-28 Organon Labor Ltd Preparations of the growth hormone
DK100792C (da) * 1961-05-23 1965-01-18 Dumex Ltd As Fremgangsmåde til fremstilling af et præparat med protraheret vitamin B12-virkning.
DE2158123A1 (de) * 1970-12-02 1972-06-08 Ciba-Geigy Ag, Basel (Schweiz) Neue pharmazeutische Präparate
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment

Also Published As

Publication number Publication date
IL79681A0 (en) 1986-11-30
CN86105023A (zh) 1988-02-24
AU596112B2 (en) 1990-04-26
ZA866052B (en) 1987-03-25
PT83187B (pt) 1988-07-01
BR8603848A (pt) 1987-03-24
DK384286A (da) 1987-02-13
AU6109286A (en) 1987-02-19
IL79681A (en) 1991-06-10
DK384286D0 (da) 1986-08-12
KR870001825A (ko) 1987-03-28
NZ217175A (en) 1989-11-28
PT83187A (en) 1986-09-01
EP0216485A1 (en) 1987-04-01
JPS6248635A (ja) 1987-03-03

Similar Documents

Publication Publication Date Title
ES2000864A6 (es) Procedimiento para la obtencion de una formulacion promotora del crecimiento de los animales
US4913906B1 (en) Controlled release dosage form of valproic acid
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
IL76440A (en) Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing them
EP0257786A3 (en) Dosage form for delivering acid sensitive beneficial agent
EP0173806A3 (en) Gallium alloy for dental restorations
EP0365779A3 (en) Cyclic grf-analogs ii
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
AU577096B2 (en) Slow release delivery of veterinary medicine
BG48204A3 (en) Method for preparing of insecticide composition
IL79765A (en) Injectable sustained release formulations of bovine somatotropin
ES480597A1 (es) Un metodo de estabilizar un compuesto activo frente a la hi-drolisis del resto enol-eter del mismo.
ES8801878A1 (es) Procedimiento de obtencion de un injerto para la administracion parental de un peptido.
AU1001183A (en) Animal collar containing pesticide and c18-c22 unsaturated essential fatty acid
EP0155623A3 (en) Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition
AU2234688A (en) Cyclic grf-analogs
IL84758A (en) Peptides stimulating the release of pituitary growth hormone in fish and amphibians,and pharmaceutical compositions containing them
JPS6463546A (en) Composition and method for accelerating growth of animal
HUT42273A (en) Insecticide compositions containing (nitro-methylene)-tetrahydro-pyrimidine derivatives as active ingredients and process for preparing the active ingredients
EP0315916A3 (en) A novel ether compound, a method for producing it, a composition containing it as an active ingredient and its use
JO1316B1 (en) The carboxylic acid resin is replaceable in preparation, uses, and pharmaceutical compositions it contains
GB1315275A (en) Insecticide
BG44221A1 (en) Composition for formulating of pesticide preparations

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-08-12

FD1A Patent lapsed

Effective date: 20001102